Alzamend Neuro Inc - Enterprise Value

The Enterprise Value as of August 2026 (TTM) for Alzamend Neuro Inc (ALZN) is 4.73M

According to Alzamend Neuro Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 4.73M. This represents a change of 60.58% compared to the average of 2.95M of the last 4 quarters.

Alzamend Neuro Inc (ALZN) Historical Enterprise Value (quarterly & annually)

How has ALZN Enterprise Value performed in the past?

The mean historical Enterprise Value of Alzamend Neuro Inc over the last ten years is 380.79M. The current 4.73M Enterprise Value has changed 24.22% with respect to the historical average. Over the past ten years (40 quarters), ALZN's Enterprise Value was at its highest in in the April 2021 quarter at 982.56M. The Enterprise Value was at its lowest in in the April 2025 quarter at -1168738.00.

Alzamend Neuro Inc (ALZN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alzamend Neuro Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alzamend Neuro Inc (ALZN) Average Enterprise Value

How has ALZN Enterprise Value performed in the past?

The current Enterprise Value of Alzamend Neuro Inc (ALZN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alzamend Neuro Inc (ALZN) Enterprise Value vs. Peers

How is ALZN’s Enterprise Value compared to its peers?

Alzamend Neuro Inc’s Enterprise Value is less than BioCardia, Inc. (4.97M), greater than Creative Medical Technology Holdings, Inc. (-3951812.00), less than HCW Biologics Inc. (6.54M), greater than Acurx Pharmaceuticals, Inc. (-6924895.00), greater than Aprea Therapeutics, Inc. (-42433104.00), greater than Adial Pharmaceuticals, Inc. (-697542.00), greater than Kiora Pharmaceuticals, Inc. (675.36K), less than NeuroSense Therapeutics Ltd. (19.59M), greater than Cardio Diagnostics Holdings, Inc. (-2920427.00), greater than Phio Pharmaceuticals Corp. (-4600542.00),

Build a custom stock screener for Alzamend Neuro Inc (ALZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alzamend Neuro Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alzamend Neuro Inc (ALZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alzamend Neuro Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.